Back to today’s briefing

Story perspectives

WHO Launches Bundibugyo Ebola Trial as Cases Climb

7/3/2026

22 2 Full Breakdown

Summary

WHO Launches Trial

WHO launched the PARTNERS trial in Democratic Republic of Congo for Bundibugyo Ebola.
The first participant enrolled on July 2 at the Ituri treatment center.
The trial tests MBP134, remdesivir and its combo against standard care, allows 1,200 patients until more than 1,000 enrollments give a clear result.
The outbreak has infected more than 1,460 people, killed 447 and adds 38 daily cases while coordination involves WHO and Congo’s INRB.

Summary

Africa CDC Declares

Africa CDC issued a continental security declaration within 24 hours of the WHO emergency designation.
The Bunia centre in Ituri is the only site testing experimental drugs for the Bundibugyo Ebola strain.
The outbreak has over 1,400 confirmed cases, ranking it as the third-largest Ebola epidemic.
By 1 July, Uganda reported 20 cases (two deaths) and France one case, showing cross-border spread, while no vaccine exists for Bundibugyo.

1 of 2

WHO Launches Trial

WHO launched the PARTNERS trial in Democratic Republic of Congo for Bundibugyo Ebola.
The first participant enrolled on July 2 at the Ituri treatment center.
The trial tests MBP134, remdesivir and its combo against standard care, allows 1,200 patients until more than 1,000 enrollments give a clear result.
The outbreak has infected more than 1,460 people, killed 447 and adds 38 daily cases while coordination involves WHO and Congo’s INRB.

1 / 2